Skip to content

Comparative Study on the Effect of Aloe Vera and Nitroglycerin Powder on the incidence and severity of phlebitis caused by peritoneal catheter

Comparative Study on the Effect of Aloe Vera and Nitroglycerin Powder on the incidence and severity of phlebitis caused by peritoneal catheter

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
IRCT
Registry ID
IRCT20181204041845N1
Enrollment
150
Registered
2019-07-15
Start date
2018-03-20
Completion date
Unknown
Last updated
2019-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

phlebitis.

Interventions

Sponsors

Sanandaj University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 70 Years

Inclusion criteria

Inclusion criteria: Hospitalization in the internal part for at least 48 hours, voluntary participation in the study, 20 to 70 years of age, having a healthy upper limb, requiring 48 hours of intravenous catheter, absence of phlebitis in the site before insertion of the angioquate, failure to receive injurious medications to the artery wall (Diazepam, midazolam, amiodarone, vitamin C, levofloxacin and ciprofloxacin), non-use of anticoagulants, the use of alcohol as an antiseptic prior to the administration of the catheter, as well as a history of vascular, systemic, diabetes, skin disease, diseases Acute and severe infections, severe anemia, glaucoma, hypotension (systolic pressure less than 100 mm) More mercury). Immune deficiency, no chemotherapy, no intravenous feeding. The type of catheter is angioquate and not attached to heparin lacquer.

Exclusion criteria

Exclusion criteria: Conditions for not admitting to the study: discharge from the hospital two days after the start of the intervention, unwillingness to continue cooperation in the study, lack of proper and timely use of the Aloe vera and nitroglycerine ointment during the study, rupture or withdrawal of the angiocontection before 48 hours , Getting sick for any reason and getting the intravenous line in the same.

Design outcomes

Primary

MeasureTime frame
Phlebitis. Timepoint: ?? 12 ???? ?? ?? ?????? ?? ???48????. Method of measurement: 5-degree phlebitis observation scale.

Secondary

MeasureTime frame
Cutaneous complications. Timepoint: Every 12 hours for 48 hours. Method of measurement: see.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad Fathi

Sanandaj University of Medical Sciences

fathi_sanan@yahoo.com+98 87 3362 7636

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026